Publication | Open Access
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
46
Citations
48
References
2021
Year
Hematological MalignancyCentral PathwayMixed-phenotype Acute LeukemiaReceptor Tyrosine KinaseMalignant Blood DisorderImmunologyAdult T-cell Leukemia-lymphomaMedicineCell BiologyCell SignalingTumor MicroenvironmentCancer ResearchSteroid Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1